Key Highlights
- Net income was $161 million, or $1.71 per diluted share, against $23.1 million, or $0.24, a year earlier.
- Net Operating Income was $179.1 million, or $1.90 per diluted share, up 47% per share.
- Full-year 2026 operating EPS guidance is now $5.05 to $5.15, with the midpoint up 9%.
- Operating Return on Equity was 14.1% excluding significant items.
- The company repurchased $60.0 million of common stock at an average of $54.52 per share.
Operating Earnings jump on strong Investment income
CNO Financial Group (NYSE:CNO) is a Carmel, Indiana insurance Holding Company that sells annuity, health and life products with a focus on middle-income households. On October 29, 2026, it reported results for the third quarter ended September 30, 2026.
Net operating income reached $179.1 million, or $1.90 per diluted share, compared with $127.2 million, or $1.29, in the prior year quarter.
Net income was $161.1 million, or $1.71 per diluted share. A year earlier it was $23.1 million, or $0.24, a period that included a $96.7 million Goodwill and other asset impairment.
What the actuarial review and one-time items contributed
Significant items tied to the comprehensive annual actuarial review had a net favorable effect of $44.9 million, or $0.48 per diluted share, on both Net Income and net operating income. In the prior year quarter, the figure was $32.2 million, or $0.33.
On a calculated basis, excluding those items, operating EPS would have been about $1.42, still above the $0.96 implied for last year's quarter.
Non-operating results included a $22.1 million charge for a valuation allowance on deferred tax Assets and $10.1 million of expense for the TechMod technology initiative.
Insurance margins and investment income drive the gain
Income from insurance products was $172.0 million, up 15% from $149.5 million. Annuity Margin was $87.9 million compared with $72.9 million, life margin was $96.0 million versus $70.6 million, and health margin was $149.1 million against $157.0 million.
Investment income not allocated to product lines rose 72% to $68.1 million, or $0.72 per share. Net investment income from general account assets was $441.5 million versus $382.9 million, an increase of about 15% on a calculated basis.
Insurance policy income increased to $688.2 million from $658.4 million. Total revenues were $1.086 billion, below $1.189 billion a year earlier.
Sales growth, Reinsurance and capital
Total new annualized premiums rose for a 17th consecutive quarter, and asset accumulation products continued to grow.
On October 1, 2026, the company closed its third reinsurance transaction with its wholly owned Bermuda affiliate, covering about $270 million of inforce graded benefit life Statutory Reserves from Colonial Penn. CEO Gary Bhojwani said the deal supports a focus on serving middle-income households.
The consolidated statutory risk-based Capital ratio was estimated at 374%. The company repurchased 1.1 million shares for $60.0 million, and has authority for another $240.4 million.
Guidance and Book Value in focus
The 2026 operating EPS range of $5.05 to $5.15 assumes an effective tax rate near 20.5% and free Cash Flow of $220 million to $240 million. Management expects 2026 operating ROE to exceed its 2027 target of 12.0% and plans to set new long-term targets in February 2027.
Book value per share was $25.34, down from $27.92 at December 31, 2025, reflecting a larger accumulated other comprehensive loss. Book value per diluted share excluding that loss was $41.29, up 8%. Readers following the name will likely watch whether sales momentum persists and how capital is deployed within the 360% to 390% risk-based capital target range.






Please wait processing your request...